New Catalyst Award Funding From Solve M.E. Advances Innovative ME/CFS and Long Covid Studies Toward Treatments
In recognition of World ME Day, Solve M.E. announced today new funding for two award-winning
May 12, 2026
In recognition of World ME Day, Solve M.E. announced today new funding for two award-winning
Dr. Liisa Selin, Dr. Ayano Kohlgruber, and Dr. Roshan Kumar received a Solve ME/CFS Catalyst
When an organization, like a government agency, company, or nonprofit, considers a big change or
Glucagon-Like Peptide-1 (GLP-1) agonist medications, like semaglutide, are injectable or oral drugs that mimic the
In our “What’s New in ME/CFS?” series, we spotlight researchers transforming what we can do
Solve M.E. is proud to support two pioneering studies through our latest round of ME/CFS
Dear Friends, As this year comes to a close, I find myself thinking not just
Dr. Akiko Iwasaki, Sterling Professor of Immunology at Yale University and winner of the 2025